FDA approves VisuMax femtosecond laser to treat myopia

The FDA approved the VisuMax femtosecond laser to surgically reduce or eliminate myopia in certain patients 22 years of age or older. The VisuMax femtosecond laser (Carl Zeiss Meditec) was approved for the small incision lenticule extraction (SMILE) procedure, which removes a small amount of eye tissue to permanently reshape the patient’s cornea, according to an FDA press release.